APA (7th ed.) Citation

Erlinge, D., Andersson, J., Fröbert, O., Törnerud, M., Böhm, F., Held, C., . . . James, S. (2024). Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent. The American heart journal, 277, 1-10. https://doi.org/10.1016/j.ahj.2024.07.016

Chicago Style (17th ed.) Citation

Erlinge, David, et al. "Rationale and Design of INFINITY-SWEDEHEART: A Registry-based Randomized Clinical Trial Comparing Clinical Outcomes of the Sirolimus-eluting DynamX Bioadaptor to the Zotarolimus-eluting Resolute Onyx Stent." The American Heart Journal 277 (2024): 1-10. https://doi.org/10.1016/j.ahj.2024.07.016.

MLA (9th ed.) Citation

Erlinge, David, et al. "Rationale and Design of INFINITY-SWEDEHEART: A Registry-based Randomized Clinical Trial Comparing Clinical Outcomes of the Sirolimus-eluting DynamX Bioadaptor to the Zotarolimus-eluting Resolute Onyx Stent." The American Heart Journal, vol. 277, 2024, pp. 1-10, https://doi.org/10.1016/j.ahj.2024.07.016.